Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Survivor: Novo Nordisk Sets Levemir Apart Amid Synthetic Insulin Scare

Jul 06 2009

• By Emily Hayes

Related Content

Public Health Trumps User Fee Goals, FDA Leaders Say – But That May Be Good News For Sponsors

Jun 01 2009

Acetaminophen Proposals Could Hit Firms Hard Via Sales And Costs

Jun 01 2009

Will Sanofi's Lantus Survive Cancer Scare? Studies Suggest a Worrisome Link

Jun 26 2009

Public Plan Drug Negotiations Could Stifle Innovation, J&J Testifies

Jun 29 2009

Dollars For Donuts: PhRMA's $80 Bil. Coup In Health Care Reform

Jun 29 2009

PhRMA Wants FDA To Explain When Decisions Depart From Committee Votes

Jun 29 2009

House Reform Bill Gives HHS Rx Price Negotiating Power Through Public Plan

Jun 29 2009

Comparative Effectiveness Council Urges Infrastructure Improvements

Jun 29 2009

FDA Looms Large As Bayer Surrenders One A Day Selenium Prostate Claims

Jun 29 2009

Generic Rx Plan B Approval Points To Possible OTC Equivalents In Near Future

Jun 29 2009

Matrixx Must Transition Zicam Customers To Oral Products As Options Narrow

Jun 29 2009

Sharfstein Heads FDA Transparency Task Force

Jun 08 2009

Victoza Outperforms Byetta In Head-To-Head Trial

Jun 08 2009

Delay, Delay, Delay: Republican Health Reform Strategy Mobilizes Into Action

Jun 18 2009

Baucus Comparative Effectiveness Proposal Runs Into Roadblock From Senior Republicans

Jun 17 2009

HELP Health Reform Bill On Fast Track With Gaps To Fill; Dodd Takes Reins

Jun 15 2009

Tight 90-Day Countdown To Create Tobacco Center Poses Challenge To FDA

Jun 15 2009

Peanut Butter Firm’s GMP “Deviation” Offers Lessons For Manufacturers

Feb 02 2009

Diabetes Drug Developers Urged To Study Higher Risk Patients By FDA Panel

Apr 27 2009

Victoza Clears European Regulators Without Thyroid Cancer Restrictions

Apr 27 2009

Acetaminophen Risk Management On Tap For Joint Advisory Panel

Apr 27 2009

Liraglutide Cancer Signal Puts Agency In Uncharted Review Territory

Apr 13 2009

Mandatory Authority May Have Slowed Latest Peanut Product Recall – Experts

Apr 13 2009

Basilea Takes On Partner J&J In Arbitration Claim Over Ceftobiprole Delays

Mar 02 2009

The Antibiotic Drought Of 2008: Plenty Of Action But No NME Approvals

Jan 26 2009

Debt Clock, Cash Situation Push Elan To Explore Options – Sale, Alliance, Merger?

Jan 13 2009

Baucus Maintains Public/Private Comparative Effectiveness Vision

Mar 16 2009

Good Trials Built On Sturdy Protocols, Not Just SPA Agreements With FDA

May 25 2009

Seen And Heard At BIO – From The IN VIVO Blog

May 25 2009

Sales & Earnings In Brief

May 11 2009

Novo Nordisk’s Liraglutide Adds Thyroid Cancer Risk To The Diabetes Safety Gauntlet

Mar 31 2009

European OTC Industry Prescribes Key Role For Pharmacists

Jun 22 2009

UK Biotech Proximagen Raises Record $80 Million ‘Asset Acquisition’ Fund

Jun 05 2009

FDA Chief of Staff Vacancy Lets Hamburg Shape Leadership Team

Jun 19 2009

FDA Resources Maintain Upward Trajectory In House Appropriations Committee Bill

Jun 19 2009

As Rumors About A Potential Acquisition Fly, Elan Names Two Dissidents To Its Board

Jun 12 2009

“Co-op Insurance” Emerges As Alternative To Health Reform Public Plan, But What Is It?

Jun 11 2009

Meet The NDAC, Minus One, As Conflict Of Interest Rules Come Into Play

Jun 22 2009

GSK Stands By Avandia: Seeks Label Change, Asks Docs To Give It Another Try

Jun 22 2009

GSK’s Viehbacher Charged To “Adapt” Sanofi-Aventis To New Realities

Sep 15 2008

FDA To Continue Providing Emerging Safety Info, But Not Through Drug Watch

Apr 02 2007

Exelixis, GSK Deal Comes To A ‘Natural, Positive End’

Jun 27 2008

Alexza’s Acute-Panic Drug Fails In Phase IIa

Jun 09 2008

Stevia Products Roll Out As GRAS, But Must Win Over Consumer Sweet Tooth

Dec 22 2008

Wisdom’s Unconventional Launch: Stevia Sweetener Without FDA’s GRAS

Jun 30 2008

Health Reform Adds Another "Yes" In Senate - But Is Magic Number 60 Or 51?

Jul 06 2009

HELP Reform Bill, Like House, Has HHS Negotiating Drug Prices In Public Plan

Jul 06 2009

Recess Time: Why A Quiet Week In Washington May Be Pivotal For Health Care Reform

Jul 06 2009

Health Care Reform And Specter Intertwined Following Party Switch

Apr 28 2009

Firms Must Pair Education With Mechanical Constraints To Reduce Overdoses

Jul 06 2009

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window